The effects of adenosine A1 receptor antagonism in patients with acute decompensated heart failure and worsening renal function: The REACH UP study

Journal of Cardiac Failure

Volumn 16, Issue 9, 2010, Pages 714-719

  Gottlieb, Stephen S ^a   Givertz, Michael M ^b   Metra, Marco ^c   Gergich, Kevin ^d   Bird, Steven ^d   Jones Burton, Charlotte ^d   Massie, Barry ^e   Cotter, Gad ^f   Ponikowski, Piotr ^g   Weatherley, Beth ^f   O'Connor, Christopher ^h   Dittrich, Howard ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Momentum Research Inc   (United States)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adenosine; cardiorenal syndrome; Heart failure; outcomes

Indexed keywords

ADENOSINE A1 RECEPTOR; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LORAZEPAM; PLACEBO; ROLOFYLLINE;

ACUTE HEART FAILURE; ACUTELY DECOMPENSATED HEART FAILURE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIURESIS; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEART VENTRICLE OVERLOAD; HOSPITAL READMISSION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PILOT STUDY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEIZURE; TREATMENT OUTCOME; WORSENING RENAL FUNCTION;

ADENOSINE A1 RECEPTOR ANTAGONISTS; AGED; CONFIDENCE INTERVALS; CREATININE; DIURETICS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; ODDS RATIO; PILOT PROJECTS; PROGNOSIS; RECEPTOR, ADENOSINE A1; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; XANTHINES;

EID: 77956187367     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.04.006     Document Type: Article

References (16)

1. S.S. Gottlieb, W. Abraham, J. Butler, D.E. Forman, E. Loh, and B.M. Massie The prognostic importance of different definitions of worsening renal function in congestive heart failure J Card Fail 8 2002 136 141
2. D.E. Forman, J. Butler, Y.F. Wang, W.T. Abraham, C.M. O'Connor, and S.S. Gottlieb Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
3. M. Metra, S. Nodari, G. Parrinello, T. Bordonali, S. Bugatti, and R. Danesi Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance Eur J Heart Fail 10 2008 188 195
4. K. Damman, G. Navis, A.A. Voors, F.W. Asselbergs, T.D.J. Smilde, and J.G.F. Cleland Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608
5. M.M. Dohadwala, and M.M. Givertz Role of adenosine antagonism in the cardiorenal syndrome Cardiovasc Ther 26 2008 276 286
6. S.S. Gottlieb, S.L. Skettino, A. Wolff, E. Beckman, M.L. Fisher, and R. Freudenberger Effects of BG9719 (CVT-124), an A(1)-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure J Am Coll Cardiol 35 2000 56 59
7. B. Greenberg, I. Thomas, D. Banish, S. Goldman, E. Havranek, and B.M. Massie Effects of multiple oral doses of an a1 adenosine antagonist, bg9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study J Am Coll Cardiol 50 2007 600 606
8. M.M. Givertz, B.M. Massie, T.K. Fields, L.L. Pearson, and H.C. Dittrich The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance J Am Coll Cardiol 50 2007 1551 1560
9. G. Cotter, H.C. Dittrich, B.D. Weatherley, D.M. Bloomfield, C.M. O'Connor, M. Metra, and B.M. Massie The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment J Card Fail 14 2008 631 640
10. M. Metra, B.M. Massie, and C.M. O'Connor Effects of rolofylline in patients with acute heart failure syndrome and renal impairment: findings from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study Eur Heart J 30 2009 abstract 3584
11. H.C. Dittrich, D.K. Gupta, T.C. Hack, T. Dowling, J. Callahan, and S. Thomson The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment J Card Fail 13 2007 609 617
12. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatine Nephron 16 1976 31 41
13. D. Boison Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies Neuroscientist 11 2005 25 36
14. R. de Silva, N.P. Nikitin, K.K.A. Witte, A.S. Rigby, H. Loh, and A. Nicholson Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure Eur J Heart Fail 9 2007 415 423
15. W. Mullens, Z. Abrahams, G.S. Francis, G. Sokos, D.O. Taylor, and R.C. Starling Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 3 2009 589 596
16. W. Mullens, Z. Abrahams, H.N. Skouri, G.S. Francis, D.O. Taylor, and R.C. Starling Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51 2008 300 306